Document is current
Any future updates will be listed below
-
Authors
Nouailles, Geraldine http://orcid.org/0000-0003-1973-3119
Adler, Julia M. http://orcid.org/0000-0001-8147-0351
Pennitz, Peter http://orcid.org/0000-0002-8132-7237
Peidli, Stefan http://orcid.org/0000-0002-4257-8690
Teixeira Alves, Luiz Gustavo http://orcid.org/0000-0002-5822-4168
Baumgardt, Morris http://orcid.org/0000-0003-2077-3716
Bushe, Judith
Voss, Anne
Langenhagen, Alina
Langner, Christine http://orcid.org/0000-0001-7311-3477
Martin Vidal, Ricardo http://orcid.org/0000-0002-9670-5640
Pott, Fabian http://orcid.org/0000-0003-3700-1691
Kazmierski, Julia http://orcid.org/0000-0002-7962-2165
Ebenig, Aileen http://orcid.org/0000-0001-7066-0184
Lange, Mona V.
Mühlebach, Michael D. http://orcid.org/0000-0002-7069-5018
Goekeri, Cengiz http://orcid.org/0000-0002-1616-4005
Simmons, Szandor
Xing, Na
Abdelgawad, Azza
Herwig, Susanne
Cichon, Günter
Niemeyer, Daniela http://orcid.org/0000-0002-1897-6365
Drosten, Christian http://orcid.org/0000-0001-7923-0519
Goffinet, Christine http://orcid.org/0000-0002-3959-004X
Landthaler, Markus http://orcid.org/0000-0002-1075-8734
Blüthgen, Nils http://orcid.org/0000-0002-0171-7447
Wu, Haibo
Witzenrath, Martin
Gruber, Achim D. http://orcid.org/0000-0002-4502-0393
Praktiknjo, Samantha D. http://orcid.org/0000-0002-0186-5271
Osterrieder, Nikolaus
Wyler, Emanuel http://orcid.org/0000-0002-9884-1806
Kunec, Dusan
Trimpert, Jakob http://orcid.org/0000-0003-1616-0810
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 1449–431232613, SFB TR84, SFB 1449–431232613, SFB TR84, OS 143/16-1, SFB TR84)
Bundesministerium für Bildung und Forschung (16GW0247, 01ZX1604B, 01ZX1906A, 16GW0247, Organo-Strat 01KX2021)
Bundesministerium für Gesundheit (CHARIS 6a)
Helmholtz Association (KA1-Co-02, KA1-Co-02)
Einstein Stiftung Berlin (EZ-2020-597 FU)
- License Information
-
More Information
Article History
Received: 30 June 2022
Accepted: 1 March 2023
First Online: 3 April 2023
Competing interests
: Related to this work, Freie Universität Berlin has filed a patent application (FU227EP - 22193939.0- 1111, Freie Universität Berlin, Germany) for the use of sCPD9 as vaccine in humans. In this application, J.T., N.O. and D.K. are named as inventors of sCPD9. Freie Universität Berlin is collaborating with RocketVax Inc. for further development of sCPD9 and receives funding for research. Independent of this work, G.N. has received project funding from Biotest AG; and M.W. received funding for research from Bayer Health Care, Biotest, Pantherna and Vaxxilon, and for lectures and advisorship from Alexion, Aptarion, Astra Zeneca, Bayer Health Care, Berlin Chemie, Biotest, Boehringer Ingelheim, Chiesi, Glaxo Smith Kline, Insmed, Novartis, Teva and Vaxxilon. The other authors declare no competing interests.
